Psychedelic Stocks Start the Week Off At All-Time Highs

Psychedelic firms have been stepping up their game, and investors have taken notice: this morning, psychedelic stocks across the sector were up substantially, with a few stand-outs experiencing significant gains. Some are likening this trend to that of early cannabis markets.

Since announcing it was working in conjunction with Health Canada on revisions to the Special Access Program (SAP) that would permit greater access to controlled substances such as MDMA and psilocybin, the stock price at Numinus Wellness (TSX-V: NUMI) (OTC: V.NUMI) has shot up from a $1.47 close on Friday to $2.20 on Monday morning. Earlier this month, it also announced a collaboration with renowned non-profit organization MAPS to study MDMA for post-traumatic stress disorder.

Click here to read more.